Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-31 @ 9:54 PM
Study NCT ID:
NCT04251533
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-05
First Post:
2020-01-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-08
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-13
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-30
First Submit QC Date:
None
Study First Post Date:
2020-02-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-28
Results First Submit QC Date:
None
Results First Post Date:
2024-07-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-31
Last Update Post Date:
2025-11-05
Last Update Post Date Type:
ESTIMATED